OHSU researchers find ‘holy grail’ for universal malaria vaccine
July 03, 2026
Research from Brandon Wilder, Ph.D., identifies malaria parasite protein fragments recognized by T cells in the liver that are shared across parasite species, offering a blueprint for a long-lasting, universal T cell-based malaria vaccine. Wilder says, “A T cell-based malaria vaccine has long been considered the field’s holy grail.”